Diagnostic and Prognostic Biomarkers in Prostate Cancer
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Clinical Diagnosis and Prognosis".
Deadline for manuscript submissions: closed (30 September 2025) | Viewed by 916
Special Issue Editor
Special Issue Information
Dear Colleagues,
Prostate cancer is one of the most common malignant tumors in men. Due to its high incidence and diagnostic complexity, it has always been a major focus of scientific research and clinical attention. In recent years, there have been developments and improvements in imaging techniques such as mpMRI, microUS, and PSMA PET/CT, which are now widely accepted and utilized. However, biomarkers, which serve as a bridge between disease status and clinical decision making, are leading the precision medicine of prostate cancer into an unprecedented new era. Despite their potential, they are still not widely utilized on a global scale. In this Special Issue, we will explore, in detail, the latest research progress, clinical application value, and future development direction of prostate cancer biomarkers, aiming to provide patients with more accurate and effective treatment strategies.
Dr. Vittorio Fasulo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- prostate cancer
- biomarker
- biopsy
- diagnosis
- prognosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
